NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy shows promise for tough nasal cancer
Disease control OngoingThis study tests a new treatment using a patient's own immune cells (dendritic cells) plus donated cell secretions to fight advanced nasopharyngeal cancer. It involves 15 people whose cancer did not fully respond to standard treatments. The main goal is to see if this therapy is …
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New pill targets virus to shrink Hard-to-Treat throat cancer
Disease control OngoingThis study tests an experimental pill, VK 2019, that blocks a key protein (EBNA1) used by the Epstein-Barr virus to drive cancer growth. It is for 13 adults with advanced nasopharyngeal cancer that is linked to EBV and has not responded to other treatments. The main goal is to se…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New cell therapy takes on hard-to-treat cancers
Disease control OngoingThis early-phase study tests an experimental cell therapy called P-MUC1C-ALLO1 in 180 adults with advanced solid tumors (e.g., breast, ovarian, lung, pancreatic cancers) that have not responded to standard treatments. The therapy uses donor immune cells engineered to target a pro…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC